Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A group of uncommon neoplasms, usually seen in the salivary glands but occurring in the breast, with a variable clinicopathologic spectrum and divided into those with myoepithelial differentiation and those without. This group includes mammary adenoid cystic carcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, acinic cell carcinoma, polymorphous low-grade adenocarcinoma and oncocytic carcinoma.
Biomarker and diagnostic research for salivary gland type cancer of the breast has been reported in the published literature.
No clinical trials have been registered for salivary gland type cancer of the breast.
33 publications have been identified in PubMed for salivary gland type cancer of the breast. Research spans Case Report / Case Series (33%), Diagnostic / Biomarker (18%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 11 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:48 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Testing and diagnosis research
6 |
18% |
Laboratory research | 6 | 18% |
Research summaries | 5 | 15% |
Disease patterns and progression | 5 | 15% |
Verma P (2026). [PMID: 42081703](https://pubmed.ncbi.nlm.nih.gov/42081703/). *Clin Nucl Med*. [Review / Meta-Analysis]
Diaz R (2026). [PMID: 41744858](https://pubmed.ncbi.nlm.nih.gov/41744858/). *Current oncology (Toronto, Ont.)*. [Case Report / Case Series]
Lefebvre N (2026). [PMID: 41468654](https://pubmed.ncbi.nlm.nih.gov/41468654/). *Journal francais d'ophtalmologie*. [Basic Science / Preclinical]
Kanitakis J (2026). [PMID: 41489577](https://pubmed.ncbi.nlm.nih.gov/41489577/). *The American Journal of dermatopathology*. [Basic Science / Preclinical]
Jones VM (2026). [PMID: 42275793](https://pubmed.ncbi.nlm.nih.gov/42275793/). *Semin Diagn Pathol*. [Review / Meta-Analysis]
Schram AM (2026). [PMID: 41777164](https://pubmed.ncbi.nlm.nih.gov/41777164/). *Future oncology (London, England)*. [Case Report / Case Series]
Rajyalakshmi R (2026). [PMID: 41520346](https://pubmed.ncbi.nlm.nih.gov/41520346/). *Diagnostic cytopathology*. [Case Report / Case Series]
Bui QH (2025). [PMID: 40555612](https://pubmed.ncbi.nlm.nih.gov/40555612/). *Pathology*. [Diagnostic / Biomarker]
Currie CC (2025). [PMID: 38661560](https://pubmed.ncbi.nlm.nih.gov/38661560/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Case Report / Case Series]
Clifton-Bligh RJ (2025). [PMID: 39655713](https://pubmed.ncbi.nlm.nih.gov/39655713/). *Endocrine-related cancer*. [Epidemiology / Natural History]